Why Did Corvus Pharmaceuticals (CRVS) Soar 10.59% Pre-Market?

On March 25, 2025, Corvus Pharmaceuticals (CRVS) saw a significant pre-market rise of 10.59%, indicating strong investor interest ahead of its upcoming earnings report.

Corvus Pharmaceuticals is set to report its earnings on March 25, 2025, which is expected to influence sentiment within the healthcare sector. The company's earnings report is highly anticipated, as it provides insights into the company's financial performance and future prospects.

Investors are closely monitoring Corvus Pharmaceuticals ahead of its earnings announcement, with options activity suggesting a potential move of +/- 30.59% in the stock price. This volatility reflects the high expectations and uncertainty surrounding the company's performance.